Radiomics Analysis of Contrast-Enhanced Breast MRI for Optimized Modelling of Virtual Prognostic Biomarkers in Breast Cancer

Objective: Breast cancer clinical stage and nodal status are the most clinically significant drivers of patient management, in combination with other pathological biomarkers, such as estrogen receptor (ER), progesterone receptor or human epidermal growth factor receptor 2 (HER2) receptor status and tumor grade.Accurate prediction of such parameters can help avoid unnecessary intervention, including unnecessary surgery.The objective was to investigate the role of magnetic resonance imaging (MRI) radiomics for yielding virtual prognostic biomarkers (ER, HER2 expression, tumor grade, molecular subtype, and T-stage).Materials and Methods: Patients with primary invasive breast cancer who underwent dynamic contrast-enhanced (DCE) breast MRI between July 2013 and July 2016 in a single center were retrospectively reviewed.Age, N-stage, grade, ER and HER2 status, and Ki-67 (%) were recorded.DCE images were segmented and Haralick texture features were extracted.The Bootstrap Lasso feature selection method was used to select a small subset of optimal texture features.Classification of the performance of the final model was assessed with the area under the receiver operating characteristic curve (AUC).Results: Median age of patients (n = 209) was 49 (21-79) years.Sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the model for differentiating N0 vs N1-N3 was: 71%, 79%, 76%, 74%, 75% AUC = 0.78 (95% confidence interval (CI) 0.72-0.85),N0-N1 vs N2-N3 was 81%, 59%, 24%, 95%, 62% AUC = 0.74 (95% CI 0.63-0.85),distinguishing HER2(+) from HER2(-) was 79%, 48%, 34%, 87%, 56% AUC = 0.64 (95% CI 0.54-0.73),high nuclear grade (grade 2-3) vs low grade (grades 1) was 56%, 88%, 96%, 29%, 61% AUC = 0.71 (95% CI 0.63-0.80);and for ER (+) vs ER(-) status the AUC=0.67(95% CI 0.59-0.76).Radiomics performance in distinguishing triple-negative vs other molecular subtypes was 0.60 (95% CI 0.49-0.71),and Luminal A 0.66 (95% CI 0.56-0.76).Conclusion: Quantitative radiomics using MRI contrast texture shows promise in identifying aggressive high grade, node positive triple negative breast cancer, and correlated well with higher nuclear grades, higher T-stages, and N-positive stages.